← brief for 2026-08-16 · People & money

Hallmarks of acute kidney injury: molecular endotypes, precision phenotyping, and phase-adapted therapy

Paper B Peer reviewed Small trial

Key takeaways

This review of kidney injury biomarkers found no evidence for using these markers to predict outcomes in patients with diabetes and MASLD. It covers molecular endotypes and precision phenotyping.

Who did this work

Hongtu Hu · Zikang Liu · Rui Ji · Yinghui Huang

Source

Paper · OpenAlex, Kidney disease concept sweep (verified C2778653478) · 2026-08-15
https://doi.org/10.1016/j.ebiom.2026.106436